Status: In Alabama, medically qualified individuals may obtain CBD oil through a physician. All other marijuana possession, use, distribution or cultivation by an individual or business is illegal.
|CBD Program||Medical Program||Recreational Program||Are Applications Open?|
|Legal||Not legal||Not legal||closed|
Number of Alabama Marijuana Business Licenses Licenses Available
Alabama Limited Medical Marijuana (CBD) Program License Guidelines
HB61 (Leni’s Law)
- authorizes the use of low THC CBD oil for the act of limited conditions that produce seizures, but is not intended as an endorsement or authorization of medical marijuana.
- CBD oil must have less than 3% measurable THC
- Individuals are only exempt from prosecution of marijuana laws if they are the patient that has been prescribed CBD oil, or the parent of a minor patient.
- Use of CBD oil as prescribed may not be used as a cause for child endangerment cases
- health insurance is not mandated to pay for such treatments
The state of Alabama currently is not accepting applications for marijuana businesses. To get ahead of the game and prepare for your marijuana business, review the resources below.
RECOMMENDED ALABAMA MARIJUANA BUSINESS PLANS FOR MARIJUANA BUSINESS APPLICATION:
- Alabama Application Guide & Checklist
- Business & Operations Plan Template
- Cultivation Plan Template
- Manufacturing/Processing Plan Template
- Environmental Plan Template
- Financial Plan Template
- Fire Safety Plan Template
- Inventory Control Plan Template
- Patient Education Plan Template
- Patient Recordkeeping Plan Template
- Product Safety Plan Template
- Security Plan Template
- Staffing Plan Template
- Suitability of Proposed Plan Template
- Transportation Plan Template
The History of Alabama Marijuana Business Licenses Marijuana
Alabama legalized a very limited medical marijuana bill in April 2, 2014 when Gov. Robert Bentley signed SB 174 (Carly’s Law) into law. The law only protects a small percentage of patients suffering from a debilitating epileptic condition for the use of CBD obtained by the University of Alabama. The law also does not allow for home cultivation or a state-regulated dispensary system.
In 2015, the Medical Marijuana Patient Safe Access Act, failed to reach the Senate floor.
In 2016, Leni’s Law expanded on Carly’s Law, allowing for a wider range of use for CBD oil, and for 3% of less THC to be present in the oil.
In June 2019, Governor Kay Ivey signed Senate Bill 236 into law to create a medical marijuana commission that will make recommendations to the Alabama Legislature next year on how to implement a medical cannabis program. The measure was a compromise after an original medical marijuana proposal hit opposition in the state House of Representatives. The Medical Cannabis Study Commission will hold a minimum of three public hearings before reporting findings to the legislature in December 2019.
On February 11, 2020, Sen. Tim Melson introduced a bill, Senate Bill 165, or the Compassion Act, that would authorize medical marijuana in Alabama, following months of study by a commission composed of doctors, legislators and lawyers. If adopted, Alabama would become the 34th state to authorize the use of marijuana to treat medical conditions. Melson sponsored a medical marijuana bill last year that passed the Senate but failed in the House.
On March 11, 2020, SB 165 was approved by the Senate. The bill went to the House for consideration, but amid the coronavirus pandemic, a vote was not held before the state’s legislative session ended on May 18, 2020. Lawmakers will most likely pick up the issue next legislative session.
In 2021, Sen. Tim Melson sponsored a new bill to legalize a medical cannabis program in the state. In March, the bill was passed by the Alabama Senate – it will now be considered in the House. To qualify for the program, patients would have to be diagnosed with one of about 20 conditions, including anxiety, sleep disorders, post-traumatic stress disorder and intractable pain. The bill also prohibits raw cannabis, smoking, vaping and candy or baked good products. Patients would instead be allowed to purchase capsules, lozenges, oils, suppositories and topical patches.